RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..2 of 2 - per page
Order by
CollaRx® & LiquiColl® Technologies
Collagen-based biodegradable matrices for localized drug delivery More
Robust Factor IX Minigene Expression Cassette: Gene Therapy for Inserting Genes that Require Liver-specific Expression
Robust Factor IX Minigene Expression Cassette: Gene Therapy for Inserting Genes that Require Liver-specific Expression More
Displaying 1..2 of 2 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development
Dec 2009 - 90 pages - $3,800
Coldwell Banker Gene Armstrong, Inc. - Company Capsule
Nov 2011 - 6 pages - $75
Gene Signal International SA. – Product Pipeline Review – Q1 2011
Mar 2011 - 34 pages - $500
Tamir Biotechnology, Inc – Product Pipeline Review – Q4 2010
Dec 2010 - 15 pages - $500
Pars Roos Biotechnology Co. - Product Pipeline Review - Q4 2010
Dec 2010 - 16 pages - $500
Personalized Medicine
Aug 2007 - 87 pages - $1,999
Gene Express, Inc. - Product Pipeline Analysis
Mar 2011 - 24 pages - $750
Stakeholder Opinions: Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of market prospects for biologics expose an opportunity for cell and gene therapies
Jul 2008 - 162 pages - $7,600
Pharmaceutical Market Trends, 2007 - 2011 Key market forecasts and growth opportunities (2nd Edition)
Nov 2007 - 173 pages - $1,860
Read-Gene (RDG) - Financial and Strategic SWOT Analysis Review
May 2011 - 25 pages - $125
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us